eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleCancer Immunotherapy
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- Renier J. Brentjens1,2,3,*,†,
- Marco L. Davila1,†,
- Isabelle Riviere1,2,3,4,†,
- Jae Park1,
- Xiuyan Wang3,4,
- Lindsay G. Cowell5,
- Shirley Bartido4,
- Jolanta Stefanski4,
- Clare Taylor4,
- Malgorzata Olszewska4,
- Oriana Borquez-Ojeda4,
- Jinrong Qu4,
- Teresa Wasielewska4,
- Qing He4,
- Yvette Bernal1,
- Ivelise V. Rijo6,
- Cyrus Hedvat6,
- Rachel Kobos7,
- Kevin Curran7,
- Peter Steinherz7,
- Joseph Jurcic1,
- Todd Rosenblat1,
- Peter Maslak1,
- Mark Frattini1 and
- Michel Sadelain1,2,3,*
- 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
- 2Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
- 3Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
- 4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
- 5Department of Clinical Sciences, UT Southwestern, Dallas, TX 75390, USA.
- 6Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
- 7Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
- ↵*Corresponding author. E-mail: brentjer{at}mskcc.org (R.B.); m-sadelain{at}ski.mskcc.org (M.S.)
-
↵† These authors contributed equally to this work.
See allHide authors and affiliations
Science Translational Medicine 20 Mar 2013:
Vol. 5, Issue 177, pp. 177ra38
DOI: 10.1126/scitranslmed.3005930
Vol. 5, Issue 177, pp. 177ra38
DOI: 10.1126/scitranslmed.3005930
Renier J. Brentjens
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
2Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
3Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Marco L. Davila
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Isabelle Riviere
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
2Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
3Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Jae Park
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Xiuyan Wang
3Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Lindsay G. Cowell
5Department of Clinical Sciences, UT Southwestern, Dallas, TX 75390, USA.
Shirley Bartido
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Jolanta Stefanski
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Clare Taylor
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Malgorzata Olszewska
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Oriana Borquez-Ojeda
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Jinrong Qu
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Teresa Wasielewska
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Qing He
4Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Yvette Bernal
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Ivelise V. Rijo
6Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Cyrus Hedvat
6Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Rachel Kobos
7Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Kevin Curran
7Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Peter Steinherz
7Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Joseph Jurcic
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Todd Rosenblat
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Peter Maslak
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Mark Frattini
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Michel Sadelain
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
2Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
3Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Submit a Response to This Article
No eLetters have been published for this article.